BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15035151)

  • 1. [Deoxypyridinoline(DPD)].
    Masaki H; Miki T
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():354-7. PubMed ID: 15035151
    [No Abstract]   [Full Text] [Related]  

  • 2. Direct, enzyme-linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorption.
    Robins SP; Woitge H; Hesley R; Ju J; Seyedin S; Seibel MJ
    J Bone Miner Res; 1994 Oct; 9(10):1643-9. PubMed ID: 7817812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary bone resorption markers (deoxypyridinoline and C-terminal telopeptide of type I collagen) in healthy persons, postmenopausal osteoporosis and patients with type I diabetes.
    Fassbender WJ; Gödde M; Brandenburg VM; Usadel KH; Stumpf UC
    Adv Med Sci; 2009; 54(1):1-6. PubMed ID: 19482729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Beta-crosslaps].
    Mori M
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():247-9. PubMed ID: 15658311
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical usefulness of measurements of urinary deoxypyridinoline (DPD) in patients with postmenopausal osteoporosis receiving intermittent cyclical etidronate: advantage of free form of DPD over total DPD in predicting treatment efficacy.
    Kitatani K; Nakatsuka K; Naka H; Miki T; Morii H; Nishizawa Y
    J Bone Miner Metab; 2003; 21(4):217-24. PubMed ID: 12811626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cross-linked N-telopeptides of type I collagen(NTX)].
    Saito S; Nakatsuka K
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():358-62. PubMed ID: 15035152
    [No Abstract]   [Full Text] [Related]  

  • 7. [Bone and bone related biochemical examinations. Bone and collagen related metabolites. DPD (total, free)].
    Takada J; Imoto K; Iba K; Yamashita T
    Clin Calcium; 2006 Jun; 16(6):994-1000. PubMed ID: 16751696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary hydroxypyridinium crosslinks of collagen in population-based screening for overt vertebral osteoporosis: results of a pilot study.
    Seibel MJ; Woitge H; Scheidt-Nave C; Leidig-Bruckner G; Duncan A; Nicol P; Ziegler R; Robins SP
    J Bone Miner Res; 1994 Sep; 9(9):1433-40. PubMed ID: 7817828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reference value for urinary deoxypyridinoline as a specific marker for measuring bone resorption in Thais.
    Pidetcha P; Intramanee S; Patrakarn K; Leelahakul P; Fongsupa S
    J Med Assoc Thai; 1999 Nov; 82(11):1136-41. PubMed ID: 10659549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of methods for measuring serum and urinary markers of bone metabolism in cats.
    DeLaurier A; Jackson B; Pfeiffer D; Ingham K; Horton MA; Price JS
    Res Vet Sci; 2004 Aug; 77(1):29-39. PubMed ID: 15120950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [N-terminal crosslinking telopeptide of type I collagen].
    Fukunaga M
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():236-9. PubMed ID: 15658308
    [No Abstract]   [Full Text] [Related]  

  • 12. [Bone resorption markers].
    Takahashi M; Inoue T
    Rinsho Byori; 1996 May; 44(5):415-22. PubMed ID: 8676559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary markers of bone resorption, pyridinoline and deoxypyridinoline, are increased in sickle cell patients with further increments during painful crisis.
    Nur E; Mairuhu W; Biemond BJ; van Zanten AP; Schnog JJ; Brandjes DP; Otten HM;
    Am J Hematol; 2010 Nov; 85(11):902-4. PubMed ID: 20882525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Type I collagen crosslinked C-telopeptides].
    Hoshino H; Kushida K
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():365-8. PubMed ID: 15035153
    [No Abstract]   [Full Text] [Related]  

  • 15. [The significance of bone biochemical markers and its application for clinics].
    Nishijima R; Kamimiya F; Horiuchi T
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():333-8. PubMed ID: 15035147
    [No Abstract]   [Full Text] [Related]  

  • 16. Markers of bone resorption--measurement in serum, plasma or urine?
    Huber F; Traber L; Roth HJ; Heckel V; Schmidt-Gayk H
    Clin Lab; 2003; 49(5-6):203-7. PubMed ID: 15285175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone resorption marker in pre- and postmenopausal females.
    Meyer-Lüerssen B; Traber L; Knörzer T; Schmidt-Gayk H
    Clin Lab; 2000; 46(5-6):285-90. PubMed ID: 10853238
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of an immunoassay method for the determination of urinary collagen crosslink excretion.
    Hata K; Miura M
    Ann Clin Biochem; 1994 Jul; 31 ( Pt 4)():374-5. PubMed ID: 7979105
    [No Abstract]   [Full Text] [Related]  

  • 19. Guidelines for the use of biochemical markers of bone turnover in osteoporosis (2004).
    Nishizawa Y; Nakamura T; Ohta H; Kushida K; Gorai I; Shiraki M; Fukunaga M; Hosoi T; Miki T; Chaki O; Ichimura S; Nakatsuka K; Miura M;
    J Bone Miner Metab; 2005; 23(2):97-104. PubMed ID: 15750686
    [No Abstract]   [Full Text] [Related]  

  • 20. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study.
    Garnero P; Hausherr E; Chapuy MC; Marcelli C; Grandjean H; Muller C; Cormier C; Bréart G; Meunier PJ; Delmas PD
    J Bone Miner Res; 1996 Oct; 11(10):1531-8. PubMed ID: 8889854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.